NVO
NYSE · Healthcare
Novo Nordisk A/S
$47.26
+1.29 (+2.81%)
EPS Surprise History
Earnings Summary
Beats (Last 5)
3/5
Avg Surprise
+3.5%
Consecutive Beats
2 quarters
Latest EPS
$6.63
YoY EPS Growth
+9.8%
History
5 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 FY2026 | $5.39 | $6.63 | +$1.24 | +23.1% | Beat |
| Dec 31, 2025 | Q4 FY2025 | $5.96 | $6.04 | +$0.08 | +1.4% | Beat |
| Sep 30, 2025 | Q3 FY2025 | $4.84 | $4.50 | -$0.34 | -7.0% | Miss |
| Jun 30, 2025 | Q2 FY2025 | $6.03 | $5.96 | -$0.07 | -1.1% | Miss |
| Mar 31, 2025 | Q1 FY2025 | $5.96 | $6.04 | +$0.08 | +1.4% | Beat |
Related Earnings News
Lilly's Q2 Growth Hinges on Mounjaro, Zepbound as Sales Projection Leans Heavily on Weight-Loss Franchise
Novo Nordisk Slips 4% as Profit Beat Fails to Quell Wegovy Worries
Amgen Lifts 2026 Forecast as Five Growth Brands Offset $772M Slump
Novo Nordisk ADR Slides Despite Strong Q2, Danish Shares Await Catch-Up